The Impact of Public Health and Social Measures (PHSMs) on SARS‐CoV‐2 Transmission in the WHO European Region (2020–2022)
Influenza and Other Respiratory Viruses · 2024-12 · 18 (12)
DOI: 10.1111/irv.70036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, online erschienen am 26.12.2024. Verfasst von Yang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London,…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Public Health, World Health Organization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, European Commission, WHO Regional Office for Europe.
Abstract (Originalsprache)
Background
Between 2020 and 2022, countries used a range of different public health and social measures (PHSMs) to reduce the transmission of SARS‐CoV‐2. The impact of these PHSMs varied as the pandemic progressed, variants of concern (VOCs) emerged, vaccines rolled out and acceptance/uptake rates evolved. In this study, we assessed the impact of PHSMs in the World Health Organization (WHO) European Region during VOC phases.
Methods
We relied on time series data on genome sequencing, PHSMs, health outcomes and physical contacts. Panel regression models were used to assess the association between PHSMs and SARS‐CoV‐2 transmission (approximated using time‐varying reproduction numbers). The interpretation of these regression models was assisted by hierarchical clustering, which was used to detect the temporal co‐occurrence of PHSMs. Generalised linear models were used to check if PHSMs are associated with physical contacts.
Results
We identified four phases based on the dominating VOC in the WHO European Region: wild type (before early 2021), Alpha (early to mid‐2021), Delta (mid‐to‐late 2021) and Omicron (after late 2021). ‘School closure’, ‘stay‐at‐home requirement’ and ‘testing policy’ were consistently associated with lower transmission across VOC phases. The impact of most PHSMs varied by VOC phases without clear increasing or decreasing trends as the pandemic progressed. Several PHSMs associated with lower transmission were not associated with fewer physical contacts.
Conclusions
The impact of PHSMs evolved as the pandemic progressed—although without clear trends. The specific mechanisms by which some PHSMs reduce SARS‐CoV‐2 transmission require further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
- Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
- World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
ORCID-Profile: Yang Liu
Förderung
- World Health Organization
- European Commission
- WHO Regional Office for Europe
Zitieren
APA
Liu, Y., Diamond, C., Abbott, S., Wong, K., Schmidt, T., Edmunds, W. J., Pebody, R., & Jit, M. (2024). The Impact of Public Health and Social Measures (PHSMs) on SARS‐CoV‐2 Transmission in the WHO European Region (2020–2022). Influenza and Other Respiratory Viruses, 18(12). https://doi.org/10.1111/irv.70036
Vancouver
Liu Y, Diamond C, Abbott S, Wong K, Schmidt T, Edmunds WJ, et al. The Impact of Public Health and Social Measures (PHSMs) on SARS‐CoV‐2 Transmission in the WHO European Region (2020–2022). Influenza and Other Respiratory Viruses. 2024;18(12). doi:10.1111/irv.70036
BibTeX
@article{Liu2024,
author = {Liu, Yang and Diamond, Charlie and Abbott, Sam and Wong, Kerry and Schmidt, Tanja and Edmunds, W John and Pebody, Richard and Jit, Mark},
title = {The Impact of Public Health and Social Measures (PHSMs) on SARS‐CoV‐2 Transmission in the WHO European Region (2020–2022)},
journal = {Influenza and Other Respiratory Viruses},
year = {2024},
volume = {18},
number = {12},
doi = {10.1111/irv.70036}
}
EUVIMED